|
The US Food and Drug
Administration (FDA)'s Nanotechnology Task Force has released a report that
recommends the agency consider developing guidance and taking other steps to
address the benefits and risks of drugs and medical devices using
nanotechnology.
"Nanotechnology holds enormous potential for use in a vast array of products,"
said Commissioner of Food and Drugs Andrew von Eschenbach, MD, who endorsed the
Task Force Report and its recommendations on July 23, 2007. "Recognizing the
emerging nature of this technology and its potential for rapid development, this
report fosters the continued development innovative safe and effective
FDA-regulated products that use nanotechnology materials."
Scientist and researchers increasingly are working in the nanoscale, creating
and using materials and devices at the level of molecules and atoms-1/100,000th
the width of a human hair.
(Ref: Chronicle Pharmabiz dated August 2, 2007)
|
|
